Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4

Francesco Piva; Matteo Santoni; Marina Scarpelli; Alberto Briganti; Antonio Lopez-Beltran; Liang Cheng; Rossana Berardi; Francesco Montorsi; Rodolfo Montironi

doi:10.1016/j.eururo.2016.02.049

Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4

Francesco Piva, Matteo Santoni, Marina Scarpelli, Alberto Briganti, Antonio Lopez-Beltran, Liang Cheng, Rossana Berardi, Francesco Montorsi, Rodolfo Montironi

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	European Urology
DOIs	https://doi.org/10.1016/j.eururo.2016.02.049
Publication status	Accepted/In press - 2016

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2016.02.049

Cite this

Piva, F., Santoni, M., Scarpelli, M., Briganti, A., Lopez-Beltran, A., Cheng, L., Berardi, R., Montorsi, F., & Montironi, R. (Accepted/In press). Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4. European Urology. https://doi.org/10.1016/j.eururo.2016.02.049

Re : Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4. / Piva, Francesco; Santoni, Matteo; Scarpelli, Marina; Briganti, Alberto; Lopez-Beltran, Antonio; Cheng, Liang; Berardi, Rossana; Montorsi, Francesco; Montironi, Rodolfo.

In: European Urology, 2016.

Research output: Contribution to journal › Article › peer-review

Piva, F, Santoni, M, Scarpelli, M, Briganti, A, Lopez-Beltran, A, Cheng, L, Berardi, R, Montorsi, F & Montironi, R 2016, 'Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4', European Urology. https://doi.org/10.1016/j.eururo.2016.02.049

Piva, Francesco ; Santoni, Matteo ; Scarpelli, Marina ; Briganti, Alberto ; Lopez-Beltran, Antonio ; Cheng, Liang ; Berardi, Rossana ; Montorsi, Francesco ; Montironi, Rodolfo. / Re : Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4. In: European Urology. 2016.

@article{dbecfae796094ebea204ab7dfe1f06a7,

title = "Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4",

author = "Francesco Piva and Matteo Santoni and Marina Scarpelli and Alberto Briganti and Antonio Lopez-Beltran and Liang Cheng and Rossana Berardi and Francesco Montorsi and Rodolfo Montironi",

year = "2016",

doi = "10.1016/j.eururo.2016.02.049",

language = "English",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Re

T2 - Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4

AU - Piva, Francesco

AU - Santoni, Matteo

AU - Scarpelli, Marina

AU - Briganti, Alberto

AU - Lopez-Beltran, Antonio

AU - Cheng, Liang

AU - Berardi, Rossana

AU - Montorsi, Francesco

AU - Montironi, Rodolfo

PY - 2016

Y1 - 2016

UR - http://www.scopus.com/inward/record.url?scp=84959294585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959294585&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2016.02.049

DO - 10.1016/j.eururo.2016.02.049

M3 - Article

AN - SCOPUS:84959294585

JO - European Urology

JF - European Urology

SN - 0302-2838

ER -